The ECMO Devices Market Landscape: Growth Drivers and Challenges

The ECMO Devices Market Landscape: Growth Drivers and Challenges

Global ECMO Devices Market Poised for Growth: Key Trends and Insights

The global Extracorporeal Membrane Oxygenation (ECMO) devices market is projected to experience a compound annual growth rate (CAGR) of 4.1% from 2024 to 2030. The increasing prevalence of chronic respiratory and cardiac conditions, coupled with technological advancements enhancing patient outcomes, is driving demand for ECMO devices. The market is further bolstered by the rising adoption of ECMO machines, continuous product innovations, and growing regulatory approvals.

Recent Developments in the ECMO Devices Market

August 2022: AirECMO, Inc., a division of Keystone Perfusion Services, partnered with REVA, a leading air ambulance provider, to enhance global ECMO transportation capabilities.
July 2022: Inspira™ Technologies introduced the Liby System, a next-generation ECMO-based life support system for patients with severe heart and lung failure.
April 2020: The U.S. FDA issued guidelines to facilitate increased availability of ECMO devices in response to the COVID-19 crisis.
April 2020: Abiomed acquired Breethe, a company specializing in ECMO technology, strengthening its portfolio for managing respiratory failure and cardiogenic shock caused by ARDS, H1N1, SARS, and COVID-19.

Market Dynamics Driving ECMO Adoption

The increasing incidence of cardiovascular and respiratory diseases is a major factor driving ECMO adoption. ECMO systems offer long-term respiratory or cardiopulmonary support by maintaining extracorporeal circulation and gas exchange.

Ischemic heart disease (IHD), also known as coronary artery disease (CAD), remains a leading global cause of mortality. A 2020 study reported that approximately 126 million people worldwide (1.72% of the population) suffer from IHD annually. The need for artificial circulatory support during cardiovascular surgeries further fuels ECMO demand.

According to the British Heart Foundation (2023), approximately 620 million individuals worldwide are affected by heart and circulatory diseases. The World Health Organization (WHO) reported that cardiovascular diseases accounted for 17.9 million deaths in 2021—representing 31% of global mortality—with projections reaching 23.6 million by 2030.

ECMO Devices Market Segmentation

The ECMO devices market is categorized based on machine modality, patient type, application, and geography:

By Machine Modality: Veno-Arterial, Veno-Venous, Arterio-Venous
By Patient Type: Pediatric, Adult
By Application: Respiratory, Cardiac, Others
By Geography: North America, Europe, Asia-Pacific, Rest of the World

The respiratory application segment is expected to command a significant market share due to the high prevalence of respiratory disorders. Asthma, a major non-communicable disease, affected 262 million people in 2019, leading to 250,000 deaths, according to WHO.

ECMO’s role in managing severe COVID-19 cases has also gained attention. The Extracorporeal Life Support Organization (ELSO) reported that ECMO improved survival rates for critically ill COVID-19 patients when conventional ventilation methods proved ineffective, with an estimated 55% survival rate among ECMO-treated patients.

North America Dominates the ECMO Market

North America leads the ECMO devices market, driven by a rising incidence of cardiovascular and pulmonary diseases, an aging population, and continuous product innovations.

The COVID-19 pandemic further accelerated demand for compact cardiopulmonary bypass systems. In October 2020, Abiomed secured FDA 510(k) clearance for its Breethe OXY-1 system, boosting ECMO adoption in the United States.

CDC data underscores the increasing demand for ECMO:

Over 795,000 Americans suffer strokes annually.
Approximately 200,000 coronary artery bypass graft surgeries are performed each year, ranking among the most common cardiac procedures.

To meet this demand, the FDA granted 510(k) clearance for Abiomed’s Breethe OXY-1 System in October 2020.

Key Players in the ECMO Devices Market

Several companies are actively shaping the ECMO market, including:

Getinge Group
Medtronic
LivaNova PLC
XENIOS AG
Terumo Corporation
MicroPort Scientific Corporation
NIPRO Corporation
OriGen Biomedical, Inc.
EUROSETS S.r.l.
ALung Technologies, Inc.
Medos Medizintechnik AG
Abiomed
Novalung
Sorin
Thoratec Corporation
MAQUET Holding B.V. Co. KG
Tianjin Medical
SHANDONG WEGO NEW LIFE MEDICAL DEVICES CO., LTD.

Future Outlook for the ECMO Devices Market

The ECMO devices market is set for steady expansion, driven by increasing cardiovascular and respiratory disease cases, technological advancements, and broader adoption of ECMO systems globally. North America remains the dominant market, supported by strong healthcare infrastructure and continuous product approvals. As key players introduce innovative solutions and new entrants emerge, the ECMO industry is poised for significant growth in the coming years.

Related Reports by DelveInsight:

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Info:

Kritika Rehani

krehani@delveinsight.com

info@delveinsight.com

www.delveinsight.com

+14699457679